RCM
ARTV

RA Capital Management’s Artiva Biotherapeutics ARTV Stock Holding History

RA Capital Management’s Portfolio ARTV Stock Details ARTV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$63.5M Hold
9,853,302
– – 0.67% 30
2025
Q4 		$42.3M Hold
9,853,302
– – 0.43% 41
2025
Q3 		$28.3M Hold
9,853,302
– – 0.35% 36
2025
Q2 		$14.9M Hold
9,853,302
– – 0.25% 42
2025
Q1 		$29.6M Hold
9,853,302
– – 0.49% 31
2024
Q4 		$99.3M Hold
9,853,302
– – 1.32% 21
2024
Q3 		$152M Buy
+9,853,302
New +$114M 1.76% 17

Other funds holding ARTV

5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RCM
Revelation Capital Management Sausalito, California $67.4M AUM
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return